Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 8 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

PREPARATIONS AND METHODS FOR TREATING A GD2 POSITIVE CANCER

Application EP-3620173-A1

European Patent Office

PREPARATIONS AND METHODS FOR TREATING A GD2 POSITIVE CANCER

Application WO-2015075194-A1

World Intellectual Property Organisation (WIPO)

Preparations and methods for treating a GD2 positive cancer

Application EP-2875827-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.